PDE5A and pulmonary arterial hypertension: In this context, phosphodiesterase 5 (PDE5) inhibitors, including Sildenafil, have been considered as the mainstay for the treatment of various forms of pulmonary hypertension [3], due to their vasodilator properties on pulmonary vasculature.